Karyopharm targets $1B revenue potential for Selinexor in myelofibrosis amid Phase 3 progress
Q4 2024 Management View Richard Paulson, President and CEO, highlighted the company's achievements in 2024, including meeting financial guidance, executing cost reduction initiatives, and advancing ...
Advances in AI can help prepare the world for the next pandemic
A perspective paper published in Nature outlines for the first time how advances in AI can accelerate breakthroughs in ...